{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T17:00:11Z","timestamp":1791910811301,"version":"4.3.4"},"reference-count":60,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medicina Cl\u00ednica"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1016\/j.medcli.2023.04.006","type":"journal-article","created":{"date-parts":[[2023,5,27]],"date-time":"2023-05-27T15:16:09Z","timestamp":1685200569000},"page":"119-127","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":43,"title":["Miastenia gravis. Actualizaci\u00f3n diagn\u00f3stica y terap\u00e9utica"],"prefix":"10.1016","volume":"161","author":[{"given":"Daniel Apolinar","family":"Garc\u00eda Est\u00e9vez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julio","family":"Pardo Fern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.medcli.2023.04.006_bib0305","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/S0025-7753(00)71529-6","article-title":"Diagn\u00f3stico y tratamiento de la miastenia grave","volume":"115","author":"Ponseti","year":"2000","journal-title":"Med Clin (Barc)."},{"key":"10.1016\/j.medcli.2023.04.006_bib0310","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1097\/01.phm.0000171169.79816.4c","article-title":"Advances in the diagnosis of neuromuscular disorders","volume":"84","author":"Meriggioli","year":"2005","journal-title":"Am J Phys Med Rehabil."},{"key":"10.1016\/j.medcli.2023.04.006_bib0315","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/S1474-4422(09)70063-8","article-title":"Autoimmune myasthenia gravis: Emerging clinical and biological heterogeneity","volume":"8","author":"Meriggioli","year":"2009","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.medcli.2023.04.006_bib0320","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1097\/WCO.0b013e3283572588","article-title":"Myasthenia and the neuromuscular junction","volume":"25","author":"Gilhus","year":"2012","journal-title":"Curr Opin Neurol."},{"key":"10.1016\/j.medcli.2023.04.006_bib0325","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1097\/WCO.0b013e328364c079","article-title":"Myasthenia gravis and the neuromuscular junction","volume":"26","author":"Querol","year":"2013","journal-title":"Curr Opin Neurol."},{"key":"10.1016\/j.medcli.2023.04.006_bib0330","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1097\/WCO.0b013e328364d6cd","article-title":"Autoimmune myasthenia gravis: Autoantibody mechanisms and new developments on immune regulation","volume":"26","author":"Le Panse","year":"2013","journal-title":"Curr Opin Neurol."},{"key":"10.1016\/j.medcli.2023.04.006_bib0335","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.jaut.2014.01.003","article-title":"Diagnosis and classification of autoimmune myasthenia gravis","volume":"48-49","author":"Berrih-Aknin","year":"2014","journal-title":"J Autoimmun."},{"key":"10.1016\/j.medcli.2023.04.006_bib0340","doi-asserted-by":"crossref","first-page":"2570","DOI":"10.1056\/NEJMra1602678","article-title":"Myasthenia gravis","volume":"375","author":"Gilhus","year":"2016","journal-title":"N Engl J Med."},{"key":"10.1016\/j.medcli.2023.04.006_bib0345","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1007\/s00415-015-7963-5","article-title":"Myasthenia gravis: A clinical-immunological update","volume":"263","author":"Binks","year":"2016","journal-title":"J Neurol."},{"key":"10.1016\/j.medcli.2023.04.006_bib0350","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.jneuroim.2016.01.018","article-title":"Titin antibodies in \u00abseronegative\u00bb myasthenia gravis \u2014 A new role for an old antigen","volume":"292","author":"Stergiou","year":"2016","journal-title":"J Neuroimmunol."},{"key":"10.1016\/j.medcli.2023.04.006_bib0355","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1001\/jamaneurol.2014.4740","article-title":"The future of research in myasthenia","volume":"72","author":"Richman","year":"2015","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.medcli.2023.04.006_bib0360","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1097\/WCO.0000000000000473","article-title":"Myasthenia gravis: New developments in research and treatment","volume":"30","author":"Evoli","year":"2017","journal-title":"Curr Opin Neurol."},{"key":"10.1016\/j.medcli.2023.04.006_bib0365","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1097\/WCO.0000000000000596","article-title":"Myasthenia gravis: From autoantobodies to therapy","volume":"31","author":"Mantegazza","year":"2018","journal-title":"Curr Opin Neurol."},{"key":"10.1016\/j.medcli.2023.04.006_bib0370","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1159\/000279334","article-title":"The incidence of myasthenia gravis: A systematic literature review","volume":"34","author":"McGrogan","year":"2010","journal-title":"Neuropidemiology."},{"key":"10.1016\/j.medcli.2023.04.006_bib0375","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/1471-2377-10-46","article-title":"A systematic review of population based epidemiological studies in myasthenia gravis","volume":"10","author":"Carr","year":"2010","journal-title":"BMC Neurol."},{"key":"10.1016\/j.medcli.2023.04.006_bib0380","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.nrl.2020.06.011","article-title":"Epidemiolog\u00eda de la miastenia gravis en la provincia de Ourense (Galicia, noroeste de Espa\u00f1a)","volume":"38","author":"Garc\u00eda-Est\u00e9vez","year":"2023","journal-title":"Neurolog\u00eda."},{"key":"10.1016\/j.medcli.2023.04.006_bib0385","doi-asserted-by":"crossref","first-page":"59","DOI":"10.33588\/rn.7602.2021201","article-title":"Epidemiolog\u00eda de la miastenia grave en la pen\u00ednsula ib\u00e9rica y Latinoam\u00e9rica","volume":"76","author":"Garc\u00eda-Est\u00e9vez","year":"2022","journal-title":"Rev Neurol."},{"key":"10.1016\/j.medcli.2023.04.006_bib0390","doi-asserted-by":"crossref","first-page":"743","DOI":"10.3389\/fneur.2020.00743","article-title":"Management of juvenil myasthenia gravis","volume":"11","author":"O\u2019Connell","year":"2020","journal-title":"Front Neurol."},{"key":"10.1016\/j.medcli.2023.04.006_bib0395","first-page":"196","article-title":"Myasthenia gravis: A disease of the very old","volume":"62","author":"Aragon\u00e8s","year":"2014","journal-title":"Neurology."},{"key":"10.1016\/j.medcli.2023.04.006_bib0400","doi-asserted-by":"crossref","first-page":"e1171","DOI":"10.1212\/WNL.0000000000008903","article-title":"Clinical and therapeutic features of myasthenia gravis in adults based on age at onset","volume":"94","author":"Cort\u00e9s-Vicente","year":"2020","journal-title":"Neurology."},{"key":"10.1016\/j.medcli.2023.04.006_bib0405","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.ncl.2018.01.003","article-title":"Ocular myasthenia","volume":"36","author":"Al-Haidar","year":"2018","journal-title":"Neurol Clin."},{"key":"10.1016\/j.medcli.2023.04.006_bib0410","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.ncl.2018.01.002","article-title":"Generalized myasthenia gravis. Classification, clinical presentation, natural history, and epidemiology","volume":"36","author":"Hehir","year":"2018","journal-title":"Neurol Clin."},{"key":"10.1016\/j.medcli.2023.04.006_bib0415","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1212\/CON.0000000000001161","article-title":"Diagnosis and mangement of myasthenia gravis","volume":"28","author":"Hehir","year":"2022","journal-title":"Continuum (Minneap Minn)."},{"key":"10.1016\/j.medcli.2023.04.006_bib0420","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1002\/mus.20950","article-title":"Lifetime course of myasthenia gravis","volume":"37","author":"Grob","year":"2008","journal-title":"Muscle Nerve."},{"key":"10.1016\/j.medcli.2023.04.006_bib0425","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.jaut.2013.12.001","article-title":"Genetic basis of myasthenia gravis. A comprehensive review","volume":"52","author":"Avidan","year":"2014","journal-title":"J Autoimmun."},{"key":"10.1016\/j.medcli.2023.04.006_bib0430","doi-asserted-by":"crossref","first-page":"102349","DOI":"10.1016\/j.autrev.2019.102349","article-title":"HLA in myasthenia gravis: From superficial correlation to underlying mechanism","volume":"18","author":"Zhong","year":"2019","journal-title":"Autoimmun Rev."},{"key":"10.1016\/j.medcli.2023.04.006_bib0435","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1212\/WNL.55.1.16","article-title":"Myasthenia gravis: Recommendations for clinical research standards. Task Force of the Medical scientific Advisory Board of the myasthenia gravis foundation of America","volume":"55","author":"Jaretzki","year":"2000","journal-title":"Neurology."},{"key":"10.1016\/j.medcli.2023.04.006_bib0440","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.ncl.2018.01.005","article-title":"An update. Myastenia gravis and pregnancy","volume":"36","author":"Hamel","year":"2018","journal-title":"Neurol Clin."},{"key":"10.1016\/j.medcli.2023.04.006_bib0445","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1111\/ane.13549","article-title":"Comorbidities in older patients with myastthenia gravis: Comparison between early and late onset disease","volume":"145","author":"Klimiec-Moskal","year":"2022","journal-title":"Acta Neurol Scand."},{"key":"10.1016\/j.medcli.2023.04.006_bib0450","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1007\/s00415-012-6478-6","article-title":"Characteristics of late-onset myasthenia gravis","volume":"259","author":"Zivkovic","year":"2012","journal-title":"J Neurol."},{"key":"10.1016\/j.medcli.2023.04.006_bib0455","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s42466-020-00091-z","article-title":"Outcomes measures and treatment effectiveness in late onset myasthenia gravis","volume":"2","author":"Pasqualin","year":"2020","journal-title":"Neurol Res Pract."},{"key":"10.1016\/j.medcli.2023.04.006_bib0460","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1016\/S0140-6736(00)05186-2","article-title":"Myasthenia gravis","volume":"357","author":"Vincent","year":"2001","journal-title":"Lancet."},{"key":"10.1016\/j.medcli.2023.04.006_bib0465","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/S1474-4422(15)00145-3","article-title":"Myasthenia gravis: Subgroup classification and therapeutic strategies","volume":"14","author":"Gilhus","year":"2015","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.medcli.2023.04.006_bib0470","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1001\/jamaneurol.2015.0203","article-title":"Clinical features and diagnostic usefulness of antibodies to clustered acetilcholine receptors in the diagnosis of seronegative myasthenia gravis","volume":"72","author":"Rodr\u00edguez Cruz","year":"2015","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.medcli.2023.04.006_bib0475","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1002\/mus.21533","article-title":"Clinical findings in MuSK-antibody positive myasthenia gravis: A U.S. experience","volume":"41","author":"Pasnoor","year":"2010","journal-title":"Muscle Nerve."},{"key":"10.1016\/j.medcli.2023.04.006_bib0480","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1002\/mus.22006","article-title":"Anti-MuSK antibody myasthenia gravis: Clinical findings and response to treatment in two large cohorts","volume":"44","author":"Guptill","year":"2011","journal-title":"Muscle Nerve."},{"key":"10.1016\/j.medcli.2023.04.006_bib0485","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.jaut.2013.12.004","article-title":"A comprehensive analysis of the epidemiology and clinical characteristics of anti-LRP4 in myasthenia gravis","volume":"52","author":"Zisimopoulou","year":"2014","journal-title":"J Autoimmun."},{"key":"10.1016\/j.medcli.2023.04.006_bib0490","doi-asserted-by":"crossref","first-page":"1976","DOI":"10.1212\/WNL.0000000000000478","article-title":"Anti-agrin autoantibodies in myasthenia gravis","volume":"82","author":"Gasperi","year":"2014","journal-title":"Neurology."},{"key":"10.1016\/j.medcli.2023.04.006_bib0495","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1111\/ane.12271","article-title":"Antititin antibody in early- and late-onset myasthenia gravis","volume":"130","author":"Szczudlik","year":"2014","journal-title":"Acta Neurol Scand."},{"key":"10.1016\/j.medcli.2023.04.006_bib0500","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.ncl.2018.01.010","article-title":"Diagnosis of myasthenia gravis","volume":"36","author":"Pasnoor","year":"2018","journal-title":"Neurol Clin."},{"key":"10.1016\/j.medcli.2023.04.006_bib0505","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1212\/WNL.0000000000002790","article-title":"International consensus guidance for management of myasthenia gravis: Executive summary","volume":"87","author":"Sanders","year":"2016","journal-title":"Neurology."},{"key":"10.1016\/j.medcli.2023.04.006_bib0510","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1111\/ene.12359","article-title":"EFNS\/ENS guidelines for the treatment of ocular myasthenia","volume":"21","author":"Kerty","year":"2014","journal-title":"Eur J Neurol."},{"key":"10.1016\/j.medcli.2023.04.006_bib0515","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1111\/nyas.13503","article-title":"The Association of British Neurologists\u2019 myasthenia gravis guidelines","volume":"1412","author":"Sussman","year":"2018","journal-title":"Ann N Y Acad Sci."},{"key":"10.1016\/j.medcli.2023.04.006_bib0520","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1007\/s00415-016-8045-z","article-title":"Clinical features, pathogenesis, and treatment of myasthenia gravis: A supplement to the guidelines of the German Neurological Society","volume":"263","author":"Melzer","year":"2016","journal-title":"J Neurol."},{"key":"10.1016\/j.medcli.2023.04.006_bib0525","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1212\/WNL.0000000000011124","article-title":"International Consensus Guidance for management of myasthenia gravis","volume":"96","author":"Narayanaswami","year":"2021","journal-title":"Neurology."},{"key":"10.1016\/j.medcli.2023.04.006_bib0530","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/s41572-019-0079-y","article-title":"Myasthenia gravis","volume":"5","author":"Gilhus","year":"2019","journal-title":"Nat Rev Dis Primers."},{"key":"10.1016\/j.medcli.2023.04.006_bib0535","doi-asserted-by":"crossref","first-page":"116648","DOI":"10.1016\/j.jns.2019.116648","article-title":"Maintenance immunosuppression in myasthenia gravis, an update","volume":"410","author":"Morren","year":"2020","journal-title":"J Neurol Sci."},{"key":"10.1016\/j.medcli.2023.04.006_bib0540","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.ad.2017.05.005","article-title":"Manejo pr\u00e1ctico de inmunosupresores en dermatolog\u00eda","volume":"109","author":"Leis-Dosil","year":"2018","journal-title":"Actas Dermosifiliogr."},{"key":"10.1016\/j.medcli.2023.04.006_bib0545","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.3390\/jcm11061597","article-title":"Current treatment of myasthenia gravis","volume":"11","author":"Alhaidar","year":"2022","journal-title":"J Clin Med."},{"key":"10.1016\/j.medcli.2023.04.006_bib0550","doi-asserted-by":"crossref","DOI":"10.1177\/1756286419876521","article-title":"Do early prednisolone and other immunosuppressant therapies prevent generalization in ocular myasthenia gravis in Western populations: A systematic review and meta-analysis","volume":"12","author":"Li","year":"2019","journal-title":"Ther Adv Neurol Disord."},{"key":"10.1016\/j.medcli.2023.04.006_bib0555","unstructured":"Miastenia gravis. En: Manual de Pr\u00e1ctica Cl\u00ednica en Neurofarmacolog\u00eda, Start&Stop. Recomendaciones diagn\u00f3stico-terap\u00e9uticas de la SEN 2019. Editores: Garc\u00eda-Azor\u00edn D, Porta-Etessam J, Guerrero-Peral AL. Editorial Luzan5, Madrid, 2019; pp. 245-262."},{"key":"10.1016\/j.medcli.2023.04.006_bib0560","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1056\/NEJMoa1602489","article-title":"Randomized trial of thymectomy in myasthenia gravis","volume":"375","author":"Wolfe","year":"2016","journal-title":"N Engl J Med."},{"key":"10.1016\/j.medcli.2023.04.006_bib0565","doi-asserted-by":"crossref","first-page":"639416420","DOI":"10.3390\/jcm11216394","article-title":"New targeted agents in myasthenia gravis and future therapeutic strategies","volume":"11","author":"S\u00e1nchez-Tejerina","year":"2022","journal-title":"J Clin Med."},{"key":"10.1016\/j.medcli.2023.04.006_bib0570","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/S1474-4422(17)30369-1","article-title":"Safety and efficacy of Eculizumab in anti-acetylcholine receptor antibody-positive refractory generalized myasthenia gravis (REGAIN): A phase 3, randomized, double-blind, placebo-controlled, multicentre study","volume":"16","author":"Howard","year":"2017","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.medcli.2023.04.006_bib0575","doi-asserted-by":"crossref","DOI":"10.1056\/EVIDoa2100066","article-title":"Terminal complement inhibitor ravulizumab in generalized myasthenia gravis","volume":"1","author":"Vu","year":"2022","journal-title":"NEJM Evid."},{"key":"10.1016\/j.medcli.2023.04.006_bib0580","unstructured":"A phase 3, multicenter, randomized, double blind, placebo-controlled study to confirm the safety, tolerability and efficacy of Zilucoplan in subjects with generalized myasthenia gravis [consultado 9 Ene 2023]. Disponible en: https:\/\/clinicaltrials.gov\/ct2\/show\/nct04115293"},{"key":"10.1016\/j.medcli.2023.04.006_bib0585","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/S1474-4422(21)00159-9","article-title":"Safety, efficacy and tolerability of Efgartigimod in patientes with generalized myasthenia gravis (ADAPT): A multicentre, randomized, placebo-controlled, phase 3 trial","volume":"20","author":"Howard","year":"2021","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.medcli.2023.04.006_bib0590","unstructured":"UCB announces positive Phase 3 results for rozanolixizumab in generalized myasthenia gravis. Newsroom. Press releases [consultado 14 Ene 2023]. Disponible en: https:\/\/www.ucb.com\/stories-media\/Press-Releases\/article\/UCB-announces-positive-Phase-3-results-for-rozanolixizumab-in-generalized-myasthenia-gravis"},{"issue":"Suppl 15","key":"10.1016\/j.medcli.2023.04.006_bib0595","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.1212\/WNL.96.15_supplement.2157","article-title":"A phase 2, multicenter, randomized, double-blind, placebo-controlled study to evaluate the safety, tolerability, efficacy, pharmacokinetics, pharmacodynamics, and immunogenicity of Nipocalimab administered to adults with generalized myasthenia gravis","volume":"96","author":"Guptill","year":"2021","journal-title":"Neurol."},{"key":"10.1016\/j.medcli.2023.04.006_bib0600","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1007\/s40120-022-00345-9","article-title":"Therapeutic effects of Batoclimab in Chinese patients with generalized myasthenia gravis. A double-blinded, randomized, placebo-controlled phase II study","volume":"11","author":"Yan","year":"2022","journal-title":"Neurol Ther."}],"container-title":["Medicina Cl\u00ednica"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002577532300218X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002577532300218X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T01:56:55Z","timestamp":1758419815000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002577532300218X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":60,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,8]]}},"alternative-id":["S002577532300218X"],"URL":"https:\/\/doi.org\/10.1016\/j.medcli.2023.04.006","relation":{},"ISSN":["0025-7753"],"issn-type":[{"value":"0025-7753","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Miastenia gravis. Actualizaci\u00f3n diagn\u00f3stica y terap\u00e9utica","name":"articletitle","label":"Article Title"},{"value":"Medicina Cl\u00ednica","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.medcli.2023.04.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Espa\u00f1a, S.L.U. All rights reserved.","name":"copyright","label":"Copyright"}]}}